drugset / Trial / NCT06501638

Efficacy and Safety of memanTine in the Treatment Of Frequently symPtomatic Atrial Premature Beats

NCT06501638

Phase 2 Completed 256 enrolled Shanghai East Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A multicenter, randomized, double-blind, placebo-controlled study to expIore the efficacy and safety of Memantine hydrochIoride tabIets to treat patients with frequent PACs.

Timeline

Start
2024-08-29
Primary completion
2025-03-21
Completion
2025-05-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Memantine Unknown 10 mg Oral